Search - tctmd.com

Displaying 621 - 640 of 891

Sort: Relevancy | Date

Presentation TCT 2015

Left Main Stent Technique and Decision Making: What We Have Learned From the ISAR LEFT Main I and II Trials

Presenter: Nicholas J. Lembo, Patrick W. Serruys, Julinda Mehilli

October 15, 2015

Presentation TCT 2015

Left Main Stent Technique and Decision Making: What We Have Learned From the DELTA Registry

Presenter: Nicholas J. Lembo, Patrick W. Serruys, Alaide Chieffo

October 15, 2015

Presentation TCT 2015

Left Main Stent Technique and Decision Making: What We Have Learned From the MITO Study

Presenter: Nicholas J. Lembo, Patrick W. Serruys, Sunao Nakamura

October 15, 2015

Presentation TCT 2015

Will Successful Adoption of Fenestrated/Branched Grafts in Complex Anatomy Improve Overall Patient Outcomes by Decreasing Off-label Usage of Standard EVAR Devices?

Presenter: Clifford J. Buckley, Zvonimir Krajcer, Christopher J. Kwolek

October 15, 2015

Presentation TCT 2015

Is AAA Incidence on the Decline in the United States, Thereby Limiting the Value of Screening?

Presenter: Clifford J. Buckley, Zvonimir Krajcer, Christopher K. Zarins

October 15, 2015

Presentation TCT 2015

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem

October 15, 2015

Presentation TCT 2015

Optimal Pharmacology in the Diabetic: What's Here? What's New? What's in the Pipeline?

Presenter: Frederick Feit, David J. Maron, Norman E. Lepor

October 15, 2015

Presentation TCT 2015

Do Contemporary DES Change the Equation for PCI vs CABG in the Diabetic Patient?

Presenter: Frederick Feit, David J. Maron, Sripal Bangalore

October 15, 2015

Presentation TCT 2015

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

Presenter: Frederick Feit, David J. Maron, Michael E. Farkouh

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Nicole Lou

October 15, 2015

News Conference News TCT 2015

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Todd Neale

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

Presentation TCT 2015

Putting It All Together: How to Manage the Patient With Atrial Fibrillation Undergoing PCI

Presenter: Gerhard C. Schuler, Matthew J. Price

October 14, 2015

Presentation TCT 2015

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Presenter: Gerhard C. Schuler, C. Michael Gibson

October 14, 2015

Presentation TCT 2015

Device-Detected, Subclinical Atrial Fibrillation: Now What?

Presenter: Gerhard C. Schuler, Freek W.A. Verheugt

October 14, 2015

Presentation TCT 2015

Integrating Imaging Into the Clinical Decision Making in Acute Stroke

Presenter: Leo Nelson Hopkins, Tudor G. Jovin

October 14, 2015

Presentation TCT 2015

Case Introduction: A Decompensated Patient With Heart Failure and Hypotension

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

Presenter: Gerhard C. Schuler, Matthew J. Price

October 14, 2015

Presentation TCT 2015

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Presenter: Pascal Vranckx, Roxana Mehran

October 14, 2015

Advertisement

Left Main Stent Technique and Decision Making: What We Have Learned From the ISAR LEFT Main I and II Trials

Left Main Stent Technique and Decision Making: What We Have Learned From the DELTA Registry

Left Main Stent Technique and Decision Making: What We Have Learned From the MITO Study

Will Successful Adoption of Fenestrated/Branched Grafts in Complex Anatomy Improve Overall Patient Outcomes by Decreasing Off-label Usage of Standard EVAR Devices?

Is AAA Incidence on the Decline in the United States, Thereby Limiting the Value of Screening?

Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies

Optimal Pharmacology in the Diabetic: What's Here? What's New? What's in the Pipeline?

Do Contemporary DES Change the Equation for PCI vs CABG in the Diabetic Patient?

Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Low 1-Year Event Rates Seen After TAVR With Sapien 3

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

Putting It All Together: How to Manage the Patient With Atrial Fibrillation Undergoing PCI

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Device-Detected, Subclinical Atrial Fibrillation: Now What?

Integrating Imaging Into the Clinical Decision Making in Acute Stroke

Case Introduction: A Decompensated Patient With Heart Failure and Hypotension

Alternatives to Anticoagulation: Left Atrial Appendage Occlusion Devices

The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content